Ufp Technologies (UFPT) AI Stock Analysis

• Market Cap: $1.72B
• Dividend Yield: N/A
• Average Volume (3M): 125.47K
• Price to Earnings (P/E): 26.2
• Beta (1Y): 1.48
• Revenue Growth: 29.47%
• EPS Growth: 23.24%
• Country: US
• Employees: 4,146
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Devices
• EPS (TTM): 2.39
• Shares Outstanding: 7,711,126
• 10 Day Avg. Volume: 166,400
• 30 Day Avg. Volume: 125,472
• PEG Ratio: 1.04
• Price to Book (P/B): 5.47
• Price to Sales (P/S): 3.72
• P/FCF Ratio: 32.93
• Enterprise Value/Market Cap: 0.98
• Enterprise Value/Revenue: 2.81
• Enterprise Value/Gross Profit: 9.86
• Enterprise Value/Ebitda: 14.97
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): 9.48
• Revenue Forecast (FY): $603.33M

• Rating: 76 Outperform
• Price Target: $252.00 ▲(26.60% Upside)

UFP Technologies' strong financial performance and positive technical indicators are the primary drivers of its stock score. While the company faces operational challenges, its growth prospects in MedTech and potential contract expansions provide a positive outlook. Valuation is moderate, and the lack of a dividend yield may limit appeal to some investors.

Positive Factors

Revenue Growth

Consistent revenue growth, particularly in the MedTech segment, indicates strong market demand and effective business strategies, supporting long-term expansion.

Successful Acquisitions

Successful integration of acquisitions enhances operational capabilities and earnings, providing a solid foundation for future growth and competitive advantage.

Contract Expansion Potential

Potential contract expansion with a major customer could significantly boost revenue and market position, ensuring sustained business growth.

Negative Factors

Labor Inefficiencies

Labor inefficiencies at the AJR facility have impacted profitability, highlighting operational challenges that could hinder growth if not addressed.

Segment Declines

Declines in key segments like Patient Services and Support can affect overall business performance, necessitating strategic adjustments to regain momentum.

Unfulfilled Orders

Unfulfilled orders due to labor issues indicate operational inefficiencies, potentially limiting revenue growth and customer satisfaction if unresolved.

Ufp Technologies Business Overview & Revenue Model

Company Description

Ufp Technologies (UFPT) is a leading manufacturer of custom-engineered foam, molded fiber, and protective packaging solutions. The company serves a diverse range of sectors, including medical, industrial, and consumer markets, providing products that enhance safety and efficiency in shipping and product use. UFPT's core offerings include packaging solutions, thermal management products, and specialized components that cater to the unique needs of its clients.

How the Company Makes Money

Ufp Technologies generates revenue primarily through the sale of its packaging products and engineered materials. The company's revenue model is centered around providing customized solutions that meet specific customer requirements, which allows it to charge premium prices for its products. Key revenue streams include direct sales to original equipment manufacturers (OEMs), distribution partnerships, and government contracts. Additionally, Ufp Technologies benefits from long-term relationships with clients in various industries, which provide stable revenue through repeat business and contracts. The company also invests in research and development to create innovative products that capture new market opportunities, further enhancing its earning potential.

Ufp Technologies Financial Statement Overview

Summary

UFP Technologies shows strong financial performance with consistent revenue growth, solid profitability, and efficient cash flow management. The balance sheet is stable with moderate leverage, supporting ongoing operations and growth initiatives.

Income Statement

Ufp Technologies has demonstrated strong revenue growth with a TTM revenue growth rate of 1.60%, indicating robust expansion. The company maintains healthy profitability with a gross profit margin of 28.76% and a net profit margin of 11.40% for the TTM. EBIT and EBITDA margins are also solid at 16.06% and 19.13%, respectively, reflecting efficient operations. Overall, the income statement shows a positive trajectory with consistent growth and profitability.

Balance Sheet

The balance sheet is stable with a debt-to-equity ratio of 0.42, indicating moderate leverage. The return on equity is strong at 18.93%, showcasing effective use of equity to generate profits. The equity ratio stands at 61.87%, reflecting a solid capital structure with a significant portion of assets financed by equity. While the company has increased its debt over time, it remains at manageable levels.

Cash Flow

Cash flow metrics are robust, with a free cash flow growth rate of 20.53% in the TTM, indicating strong cash generation capabilities. The operating cash flow to net income ratio is 1.20, suggesting efficient conversion of income into cash. Additionally, the free cash flow to net income ratio of 0.87 highlights the company's ability to generate cash relative to its net income. Overall, cash flow performance is strong, supporting the company's growth and operational needs.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	597.95M	504.42M	400.07M	353.79M	206.32M	179.37M
Gross Profit	170.50M	146.69M	112.22M	90.26M	51.11M	44.68M
EBITDA	112.27M	95.80M	68.95M	67.37M	29.65M	24.63M
Net Income	67.12M	58.98M	44.92M	41.79M	15.89M	13.37M
Balance Sheet
Total Assets	652.82M	629.00M	404.14M	378.19M	334.13M	203.20M
Cash, Cash Equivalents and Short-Term Investments	18.23M	13.45M	5.26M	4.45M	11.12M	24.23M
Total Debt	146.12M	206.03M	46.04M	68.37M	84.36M	2.21M
Total Liabilities	248.91M	286.24M	118.05M	140.65M	139.69M	26.31M
Stockholders Equity	403.91M	342.76M	286.09M	237.54M	194.45M	176.89M
Cash Flow
Free Cash Flow	54.88M	56.94M	30.84M	3.96M	8.90M	20.67M
Operating Cash Flow	63.56M	66.59M	41.33M	17.74M	14.29M	25.04M
Investing Cash Flow	-12.35M	-210.16M	-10.49M	1.29M	-101.46M	-4.26M
Financing Cash Flow	-52.50M	152.39M	-30.02M	-25.89M	74.05M	-285.00K

Ufp Technologies Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 199.05
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For UFPT, the sentiment is Positive. The current price of 199.05 is below the 20-day moving average (MA) of 202.79, below the 50-day MA of 201.03, and below the 200-day MA of 223.11, indicating a bullish trend. The MACD of 5.59 indicates Negative momentum. The RSI at 63.37 is Neutral, neither overbought nor oversold. The STOCH value of 55.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for UFPT.

Ufp Technologies Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
UFPT	76 Outperform	$1.72B	26.20	18.31%	―	29.47%	23.24%
AHCO	70 Neutral	$1.40B	17.63	4.77%	―	-0.23%	―
CNMD	66 Neutral	$1.41B	12.91	6.60%	1.80%	4.69%	-51.57%
AORT	62 Neutral	$2.24B	―	-2.45%	―	9.81%	-1066.50%
SIBN	57 Neutral	$662.64M	―	-14.18%	―	22.93%	43.83%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
IART	45 Neutral	$873.95M	―	-38.71%	―	4.99%	-7151.40%

Ufp Technologies Corporate Events

UFP Technologies’ Earnings Call: Growth Amid Challenges

The recent earnings call for UFP Technologies presented a mixed sentiment, highlighting both positive growth and notable challenges. The company reported significant advancements in key business areas such as MedTech and robotic surgery, alongside successful integration of recent acquisitions. However, labor inefficiencies at the AJR facility and declines in certain segments posed significant challenges. Despite these hurdles, UFP Technologies expressed optimism about future growth, particularly with ongoing discussions to expand major contracts, although current inefficiencies remain a concern.

UFP Technologies Reports Robust Q3 2025 Performance

UFP Technologies, Inc. is a contract development and manufacturing organization specializing in single-use and single-patient medical devices, serving as a crucial partner in the medical device supply chain. In its latest earnings report for the third quarter of 2025, UFP Technologies announced a net income of $16.4 million, consistent with the previous year, and sales of $154.6 million, marking a 6.5% increase from the same period in 2024. The company also reported year-to-date sales of $453.9 million, a significant 26% rise compared to the previous year.

UFP Technologies Highlights Strategic Focus in Investor Update

UFP Technologies has released updated presentation materials for investor meetings, highlighting its strategic focus on the medical device industry. The company emphasizes its innovative process from design to delivery, aiming to strengthen customer relationships and expand in high-margin markets. The presentation outlines the company’s growth strategies, including shifting its business to higher-margin opportunities and expanding its presence in various markets such as medical, aerospace, and defense. These updates are expected to enhance UFP Technologies’ market positioning and operational efficiency, potentially impacting stakeholders positively.

The most recent analyst rating on (UFPT) stock is a Buy with a $244.00 price target. To see the full list of analyst forecasts on Ufp Technologies stock, see the UFPT Stock Forecast page.